A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain (clinicaltrials.gov) - Oct 16, 2026 - P2 | N=45 | Not yet recruiting | Sponsor: Adneuris Therapeutics, Inc.
New P2 trial • Addiction (Opioid and Alcohol) • Pain • Substance Abuse
|